Key Neurological Disorders

Why This Matters

Neurological disorders aren't just a list of symptoms to memorize. They're windows into how the brain actually works. When you study Alzheimer's, you're learning about memory consolidation. When you examine Parkinson's, you're seeing the dopamine system in action. Every disorder on this list reveals something fundamental about neural communication, brain structure, neurotransmitter function, or the relationship between genes and behavior. That's exactly what you're being tested on.

On exams, you'll need to connect specific disorders to their underlying mechanisms. Why does damage to the substantia nigra cause movement problems? How does demyelination disrupt neural signaling? Don't just memorize that "Alzheimer's causes memory loss." Know why amyloid plaques and tau tangles lead to cognitive decline, and how that connects to what you've learned about synaptic function and neural plasticity.

---

Neurodegenerative Disorders: Progressive Neural Loss

These disorders share a common theme: the gradual death of specific neuron populations, leading to progressive decline in function. What makes each unique is which neurons die and where.

Alzheimer's Disease

• Amyloid plaques and neurofibrillary tau tangles are the two hallmark protein accumulations. Amyloid-beta plaques build up between neurons and interfere with cell-to-cell signaling, while tau tangles form inside neurons and collapse the transport system that keeps them alive. Together, they cause widespread neuron death, primarily in the hippocampus and cortex.
• Progressive memory loss begins with recent memories because the hippocampus, which is essential for forming new memories, is affected earliest. Older memories stored in the cortex tend to be preserved longer.
• Acetylcholine deficits result from damage to cholinergic neurons in the basal forebrain (especially the nucleus basalis of Meynert). This is why cholinesterase inhibitors, which prevent the breakdown of acetylcholine in the synapse, are a common treatment approach. They don't stop the disease, but they can temporarily boost the remaining acetylcholine signaling.

Parkinson's Disease

• Dopamine-producing neurons in the substantia nigra degenerate, disrupting the basal ganglia circuit that controls voluntary movement. The substantia nigra normally sends dopamine to the striatum via the nigrostriatal pathway, and without that input, the motor circuit can't properly initiate or regulate movement.
• Motor symptoms include resting tremor, rigidity, and bradykinesia (slowness of movement). These reflect the loss of dopamine's role in initiating and smoothing movement. Treatment with L-DOPA (a dopamine precursor that can cross the blood-brain barrier) helps replace the missing dopamine.
• Non-motor symptoms including depression, sleep disturbances, and loss of smell often appear years before motor signs, suggesting that neurodegeneration begins in brainstem regions and spreads to the substantia nigra over time.

Huntington's Disease

• HTT gene mutation on chromosome 4 involves an expanded CAG trinucleotide repeat. The longer the repeat, the earlier symptoms tend to appear. This mutation causes production of abnormal huntingtin protein, which is toxic to neurons, leading to cell death in the striatum (caudate and putamen) and cortex.
• Autosomal dominant inheritance means only one copy of the mutated gene is needed, giving offspring of an affected parent a 50% chance of inheriting the mutation. This makes Huntington's a key example of single-gene neurological disorders.
• Chorea (involuntary, dance-like movements) results from damage to inhibitory medium spiny neurons in the striatum. Normally, these neurons help suppress unwanted movements through the indirect pathway of the basal ganglia. When they die, that inhibition is lost, causing uncontrolled motor output.

Amyotrophic Lateral Sclerosis (ALS)

• Motor neurons in the brain and spinal cord progressively die, causing muscle weakness, atrophy, and eventual paralysis. The disease typically begins in one region (often a limb or the bulbar muscles controlling speech and swallowing) and spreads.
• Cognitive function is typically preserved, at least early in the disease. This distinguishes ALS from other neurodegenerative disorders and highlights the specificity of neural vulnerability: the disease targets motor neurons while largely sparing sensory neurons and higher cognitive circuits. (Note: a subset of ALS patients do develop frontotemporal dementia.)
• Both upper and lower motor neurons are affected, producing a characteristic combination of spasticity (from upper motor neuron loss) and muscle wasting with fasciculations (from lower motor neuron loss). This dual involvement is a key diagnostic feature.

---

Disorders of Neural Communication: Signaling Gone Wrong

These conditions demonstrate what happens when the transmission of neural signals is disrupted, whether through demyelination, abnormal electrical activity, or neurotransmitter imbalances.

Multiple Sclerosis

• Demyelination of nerve fibers occurs when the immune system mistakenly attacks myelin sheaths in the CNS. Myelin normally insulates axons and enables fast saltatory conduction (where action potentials jump between nodes of Ranvier). Without it, signals slow dramatically or fail entirely.
• Unpredictable relapses and remissions reflect the immune system's fluctuating activity and the brain's attempts at remyelination. During remission, oligodendrocytes may partially repair myelin, restoring some function.
• Diverse symptoms (vision problems, fatigue, numbness, motor dysfunction) depend on which neural pathways lose their myelin coating. Optic neuritis (inflammation of the optic nerve) is a common early symptom.

Epilepsy

• Abnormal synchronous electrical activity in the brain causes seizures. Normally, neurons fire in coordinated but varied patterns. During a seizure, too many neurons fire together in lockstep.
• Seizure types vary based on where abnormal activity originates and how far it spreads. Focal seizures start in one brain region and may stay localized, while generalized seizures involve both hemispheres from the start (including tonic-clonic seizures with convulsions and absence seizures with brief lapses in awareness).
• Excitation-inhibition imbalance is the core mechanism. This often involves disrupted GABA (the brain's main inhibitory neurotransmitter) or excessive glutamate (the main excitatory neurotransmitter) signaling. Many anti-epileptic drugs work by enhancing GABA activity or reducing glutamate activity.

Schizophrenia

• Dopamine hypothesis: excess dopamine activity in mesolimbic pathways contributes to positive symptoms like hallucinations and delusions. The strongest evidence comes from the fact that antipsychotic drugs work by blocking $D_2$ dopamine receptors, and drugs that increase dopamine (like amphetamines) can produce psychotic symptoms.
• Positive symptoms (hallucinations, delusions, disorganized speech) vs. negative symptoms (flat affect, social withdrawal, reduced motivation) likely involve different neural circuits. Positive symptoms are linked to mesolimbic dopamine excess, while negative symptoms may involve dopamine deficits in the prefrontal cortex (mesocortical pathway).
• Prefrontal cortex dysfunction contributes to cognitive symptoms and disorganized thinking, linking directly to what you've learned about executive function, working memory, and planning.

---

Vascular and Acute Disorders: Sudden Disruption

Unlike progressive disorders, these conditions involve rapid onset due to interrupted blood flow or other acute events.

Stroke

• Ischemic strokes (caused by a blood clot blocking an artery) account for ~87% of cases; hemorrhagic strokes (caused by a ruptured blood vessel bleeding into brain tissue) are less common but often more severe.
• Time-critical treatment: neurons begin dying within minutes of oxygen deprivation because the brain has almost no energy reserves and depends on constant blood flow. For ischemic strokes, clot-dissolving drugs (tPA) must be administered within a narrow time window (generally 4.5 hours) to limit damage.
• Localized damage produces symptoms that map onto affected brain regions. Left hemisphere strokes often cause aphasia (language deficits), while right hemisphere strokes may cause hemispatial neglect (the patient ignores the left side of space). This is why studying stroke patients has taught us so much about functional localization in the brain.

Migraine

• Cortical spreading depression (CSD) is a wave of intense neuronal depolarization that slowly moves across the cortex, followed by a period of suppressed activity. CSD is thought to underlie migraine aura (the visual disturbances some patients experience before the headache).
• Trigeminovascular system activation causes the characteristic throbbing pain. The trigeminal nerve releases inflammatory neuropeptides around blood vessels and the meninges, producing pain and vasodilation.
• Neurotransmitter involvement: serotonin and CGRP (calcitonin gene-related peptide) are key signaling molecules. Triptans (which activate serotonin receptors) and newer CGRP-blocking antibodies are both effective treatments, confirming the role of these molecules in migraine pathophysiology.

---

Neurodevelopmental Disorders: Altered Brain Development

These conditions emerge during brain development and reflect differences in how neural circuits form and function rather than degeneration of existing structures.

Autism Spectrum Disorders

• Spectrum presentation: symptoms range from mild social difficulties to significant communication and behavioral challenges, reflecting variable neural differences across individuals. The term "spectrum" captures this wide range.
• Altered connectivity patterns: research suggests differences in both local and long-range neural connections, affecting how different brain regions integrate information. Some studies find increased local connectivity but reduced long-range connectivity, though findings vary.
• Early brain overgrowth in some cases, followed by atypical synaptic pruning, points to disrupted developmental processes during critical periods. This connects to what you've learned about how the brain normally refines its circuits through experience-dependent pruning.

---

Quick Reference Table

---

Self-Check Questions

1. Both Parkinson's disease and Huntington's disease affect the basal ganglia. How do their movement symptoms differ, and what does this reveal about the different roles of dopamine vs. the striatum in motor control?

2. If a patient presents with memory problems, how would you distinguish early Alzheimer's disease from the cognitive effects of a stroke based on symptom onset and progression?

3. Multiple sclerosis and ALS both cause motor dysfunction. What is the key mechanistic difference between demyelination and motor neuron death, and how would symptoms differ?

4. Compare the dopamine hypothesis of schizophrenia with the dopamine deficit in Parkinson's disease. Why might increasing dopamine help one condition but worsen the other?

5. An exam question asks you to explain how studying neurological disorders helps us understand normal brain function. Using two disorders from this guide, explain what each reveals about a specific brain structure or neurotransmitter system.